The bill mandates that the Alabama Medicaid Agency provide coverage for specific noninvasive colorectal cancer screening tests that receive a grade A or B from the United States Preventive Services Task Force. The tests included under this coverage are the guaiac fecal occult blood test (gFOBT), the fecal immunochemical test (FIT), and the multi-target stool DNA test (sDNA-FIT). Additionally, the bill requires that a colonoscopy be covered if it is performed following a positive result from one of these screening tests.

This legislation will be effective starting October 1, 2025, and includes a provision for repeal two years after its effective date. The new legal language inserted into the current law includes the requirement for coverage of the specified screening tests and colonoscopies, while no deletions from existing law are noted in the text provided.